Presthera provides access to a curated portfolio of advanced wound care solutions designed to support a wide range of patient needs and reimbursement environments. Our offerings span Skin Substitute products, autologous blood-derived solutions, and advanced debridement technologies, allowing clinicians to tailor care based on clinical presentation and payer considerations. By aligning therapy selection with both patient appropriateness and reimbursement integrity, Presthera helps wound programs deliver high-quality outcomes while maintaining operational and financial sustainability.